Thrombomodulin Mitigates the Progression of Hepatocellular Carcinoma in Steatotic Liver
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common hepatic disorder in developed countries. MASLD, including the more aggressive metabolic dysfunction-associated steatohepatitis (MASH), is associated with …